GW & Wade’s Sempra SRE Stock Holding History

GW & Wade’s Portfolio SRE Stock Details SRE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-3,189	Closed	-$217K	–	439
2023 Q3	$217K	Buy	+3,189	New	+$230K	0.01%	371

Other funds holding SRE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Newport Trust Company Washington, District of Columbia $41.5B AUM 16.76% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

GW & Wade's SRE Position: Q4 2023 in Review

GW & Wade sold out of Sempra (SRE) in Q4 2023, closing a stake of 3,189 shares — an estimated $217K sold.

GW & Wade first reported a position in SRE in Q3 2023 and held it in 1 quarter. The position peaked at $217K in Q3 2023. 1,040 funds tracked by Wall St. Rank hold SRE as of Q4 2023.

GW & Wade reported no remaining Sempra position as of Q4 2023 after selling out during the quarter.
GW & Wade sold 3,189 Sempra shares in Q4 2023, an estimated $217K.
GW & Wade first reported a position in Sempra in Q3 2023 and held it in 1 quarter.
GW & Wade's Sempra position peaked at $217K in Q3 2023.
1,040 funds tracked by Wall St. Rank held Sempra as of Q4 2023.

Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.